Related Experiment Video
Updated: Sep 28, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention
Wen-Juan Xiu1, Hai-Tao Yang1, Ying-Ying Zheng1,2
1Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Insights
The albumin/derived neutrophil and lymphocyte ratio (ALB-dNLR) score predicts mortality in patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI). Higher ALB-dNLR scores are associated with increased risks of all-cause and cardiac mortality post-PCI.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation Markers
Background:
- The prognostic value of the albumin/derived neutrophil and lymphocyte ratio (ALB-dNLR) in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains unclear.
- Inflammatory markers are increasingly recognized for their role in cardiovascular disease outcomes.
Purpose of the Study:
- To investigate the association between the ALB-dNLR score and patient outcomes following PCI.
- To determine if ALB-dNLR can serve as a predictive biomarker for mortality in CAD patients post-PCI.
Main Methods:
- A cohort of 6,050 patients undergoing PCI was analyzed.
- Patients were stratified into three groups based on ALB-dNLR scores.
- Cox proportional hazard models were used to assess the predictive value of ALB-dNLR for all-cause mortality (ACM) and cardiac mortality (CM).
Main Results:
- Significant differences in ACM and CM rates were observed across ALB-dNLR score groups.
- The ALB-dNLR score independently predicted both ACM and CM in multivariate analysis.
- These predictive associations were also observed specifically in male patients.
Conclusions:
- The ALB-dNLR score is a reliable predictor of mortality in patients with CAD after PCI.
- Elevated ALB-dNLR scores indicate a higher risk of adverse outcomes, including death, post-PCI.
Background:
The influence of the albumin/derived neutrophil and lymphocyte ratio (ALB-dNLR) on the outcomes of patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI) is not known. Here, we aimed to determine the association between the ALB-dNLR score and post-PCI CAD patient outcomes.
Methods:
A total of 6,050 patients from the First Affiliated Hospital of Xinjiang Medical University were enrolled between January 2008 and December 2016. These patients were divided into three groups according to their ALB-dNLR scores (0 points, n = 1,121; 1 point, n = 3,119; 2 points, n = 1,810). Mortality after PCI [all-cause (ACM) and cardiac (CM)] was taken as the primary endpoint. The prognostic value of the ALB-dNLR score was determined with the Cox proportional hazard model after adjustment for covariates.
Results:
The ACM and CM rates differed among participants in the three groups (P = 0.007 and P = 0.034, respectively). Multivariate Cox analysis showed that the ALB-dNLR score independently predicted both ACM [1 point vs. 0 points, HR = 1.249 (95% CI: 0.79-1.774), P = 0.215; 2 points vs. 0 points, HR = 1.777 (95% CI: 1.239-2.549), P = 0.002] and CM [1 point vs. 0 points, HR = 1.294 (95% CI: 0.871-1.922), P = 0.202; 2 points vs. 0 points, HR = 1.782 (95% CI: 1.185-1.782), P = 0.027]. We also found that among male patients in the three groups, both ACM and CM rates differed (P = 0.006 and P = 0.017, respectively). Multivariate Cox analysis showed that the ALB-dNLR score independently predicted both ACM [1 point vs. 0 points, HR = 1.237 (95% CI: 0.806-0.330), P = 0.330; 2 points vs. 0 points, HR = 1.790 (95% CI: 1.159-2.764), P = 0.009] and CM [1 point vs. 0 points HR = 1.472 (95% CI: 0.892-2.430), P = 0.130; 2 points vs. 0 points, HR = 1.792 (95% CI: 1.182-3.289), P = 0.009].
Conclusion:
The ALB-dNLR score is a credible predictor for mortality in patients with CAD who have undergone PCI.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...